B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Regorafenib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Regorafenib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cep
20 shared targets
tivozanib
19 shared targets
ponatinib
25 shared targets
lenvatinib
15 shared targets
bafetinib
15 shared targets
cabozantinib
15 shared targets
golvatinib
16 shared targets
nilotinib
21 shared targets
semaxanib
10 shared targets
motesanib
16 shared targets
Loading evidence profile...

This evidence profile for Regorafenib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.